Aurinia Pharmaceuticals, Inc. (AUPH)

15.04 +0.89 (+6.29%) USD  |  NASDAQ  |  Mar 04, 16:00
15.14 +0.10 (+0.66%) After-Hours: 20:00
More

Aurinia Pharmaceuticals Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for AUPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
Xenon Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Edesa Biotech, Inc. Upgrade
Lexaria Bioscience Corp. Upgrade
ProMIS Neurosciences, Inc. Upgrade